We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with ad... Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with advanced solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod. Show more
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...
Phase 2/3 Orbit Study and Phase 3 Cosmic Study of setrusumab in Osteogenesis Imperfecta expected to complete enrollment around the end of first quarter and in the first half of 2024, respectively...
LONDON, March 05, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.442 | -14.6260754467 | 3.022 | 3.07 | 2.58 | 1102147 | 2.74178902 | CS |
4 | -0.44 | -14.5695364238 | 3.02 | 3.48 | 2.58 | 1037367 | 3.03927626 | CS |
12 | -0.43 | -14.2857142857 | 3.01 | 4.36 | 2.58 | 1564922 | 3.54573625 | CS |
26 | 1.04 | 67.5324675325 | 1.54 | 4.36 | 1.54 | 1400483 | 2.96055874 | CS |
52 | 1.54 | 148.076923077 | 1.04 | 4.36 | 0.9201 | 1495108 | 2.06725213 | CS |
156 | -0.71 | -21.5805471125 | 3.29 | 4.36 | 0.301 | 1454086 | 1.75567025 | CS |
260 | -3.97 | -60.6106870229 | 6.55 | 6.5659 | 0.301 | 1144543 | 2.15528839 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions